North America Blood Glucose Monitoring Devices Market Expected to Reach $9.93 Billion by 2030

North American market for blood glucose monitoring devices is thriving, with a forecasted worth of $9.93 billion in 2030, a substantial increase from $6.52 billion in 2025. This growth can be attributed to the growing number of individuals diagnosed with diabetes, particularly Type 2 diabetes, in the region. Monitoring blood glucose levels has become an essential part of disease management, with patients increasingly monitoring their condition outside clinical settings. Advancements in monitoring technologies, such as continuous glucose monitoring systems and digitally connected meters, have made tracking glucose levels more practical and precise for everyday use. These improvements allow patients to better understand glucose trends and make informed decisions about their lifestyle and treatment options.

Despite these advancements, challenges such as higher device prices, limited access to advanced technologies in certain care environments, and usability issues among elderly or newly diagnosed patients may hinder adoption in some segments of the market. Nevertheless, the overall outlook for the market remains optimistic, driven by continuous innovation and a sustained demand for reliable glucose monitoring solutions.

In terms of product types, the self-monitoring blood glucose systems segment holds the largest share in the North America blood glucose monitoring devices market. Self-monitoring blood glucose systems are widely used for day-to-day management of diabetes in various settings, including home care and outpatient facilities. These devices are commonly used for routine glucose testing by patients with Type 2 diabetes, recently diagnosed individuals, and those who do not require continuous monitoring. The convenience of these devices, their availability through retail channels, and ongoing product enhancements have contributed to their widespread adoption in the region.

Regarding applications, the diabetes management segment is expected to experience the highest growth rate during the forecast period. This growth is driven by the high prevalence of Type 1 and Type 2 diabetes in North America and the emphasis on tight glycemic control. Blood glucose monitoring is a critical component of diabetes management, aiding in insulin dosing, medication adjustments, and dietary planning. The adoption of continuous glucose monitoring systems has further strengthened this segment by enabling real-time tracking of glucose levels, trend analysis, and early identification of glycemic fluctuations.

The United States is projected to dominate the North America blood glucose monitoring devices market during the forecast period. Factors contributing to this dominance include the high prevalence of diabetes in the country, advanced healthcare infrastructure, and the population’s readiness to embrace modern technologies. With approximately 38.5 million individuals in the US living with diabetes in 2024 according to the International Diabetes Federation, there is a consistent demand for accurate and convenient glucose monitoring solutions in the country.

In conclusion, the North America blood glucose monitoring devices market is poised for significant growth in the coming years, driven by technological advancements, increasing prevalence of diabetes, and a strong focus on effective disease management across the region. With a wide range of products and applications available, the market is expected to continue expanding to meet the evolving needs of patients and healthcare providers in managing diabetes.